The U.S. Food and Drug Administration has approved Caplyta (lumateperone) as an adjunctive therapy with antidepressants for ...

Kallmann Syndrome is a rare genetic disorder that causes delayed puberty and a poor sense of smell. New DNA findings suggest ...

The FDA has approved Caplyta as adjunctive therapy with antidepressants to treat major depressive disorder in adults, ...

The findings are the focus of a Channel 4 documentary, which reports that evidence points to Hitler having Kallmann syndrome.

Led by University of Cincinnati and Cincinnati Children’s researchers, new trial results published in The Lancet Psychiatry found the drug metformin can help manage weight gain in youth taking ...

The Dutchman had been charged with allegations of drug trafficking, assault causing bodily harm, destruction of property and ...

New findings reported in JAMA Network Open from a longitudinal cohort study utilizing electronic health records (EHRs) show that individuals with a prior serious mental illness (SMI), including ...

Caplyta’s most recent FDA approval is based on positive results from two Phase III clinical trials: Study 501 (NCT04985942) and Study 502 (NCT05061706). Both studies met their primary endpoint and key ...

Testimony in the wrongful death lawsuit against the Los Angeles Angels underscores the difficulties team attorneys face ...

AI-generated personalized bipolar management plans present growth opportunities driven by rising mental health awareness, ...